| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 02/24/2000 | WO2000009157A1 Protein delivery system using human papillomavirus virus-like particles |
| 02/24/2000 | WO2000009145A1 Treatment of tumors with oligonucleotides directed to insulin-like growth factor-i receptor |
| 02/24/2000 | WO2000009140A1 Composition and method of using tumor cells |
| 02/24/2000 | WO2000009139A2 Methods for promoting survival of myelin producing cells |
| 02/24/2000 | WO2000008924A1 Method of performing transgenesis |
| 02/24/2000 | WO2000002905A3 Methods for accelerating bone and cartilage growth and repair |
| 02/24/2000 | WO1999065947A3 Monoclonal antibodies directed against the g3bp protein, and uses |
| 02/24/2000 | WO1999064565A3 Regulation of hematopoietic stem cell differentiation by the use of human mesenchymal stem cells |
| 02/24/2000 | WO1999061605A9 System for reproducing and modulating stability and turnover of rna molecules |
| 02/24/2000 | WO1999061597A9 Expression cassette for transformation comprising a modified viral sequence driven by a suitable promoter |
| 02/24/2000 | WO1999058692A3 Human apoptosis associated proteins |
| 02/24/2000 | WO1999058684A3 Compounds from moraxella catarrhalis |
| 02/24/2000 | WO1999053046A3 Noncloning technique for expressing a gene of interest |
| 02/24/2000 | WO1999045127A3 Enhanced prodrug activation |
| 02/24/2000 | WO1999042586A3 Exo1 and exo2, exocytotic proteins |
| 02/24/2000 | WO1999009139A9 Retrovirus and viral vectors |
| 02/24/2000 | DE19837438A1 Recombinant human cell for forming bone and cartilage cells from undifferentiated mesenchyme is capable of expressing a member of the T-box family of transcription factors |
| 02/24/2000 | CA2348388A1 Gene regulating circadian clock function and photoperiodism |
| 02/24/2000 | CA2340428A1 A single gene encoding aortic-specific and striated-specific muscle cell isoforms, its regulatory sequences and uses thereof |
| 02/24/2000 | CA2340242A1 Method of performing transgenesis |
| 02/24/2000 | CA2340199A1 Mammalian transgenesis by intracytoplasmic sperm injection |
| 02/24/2000 | CA2340181A1 Transgenic plants and plant cells comprising a reduced expression of invertase inhibitors |
| 02/24/2000 | CA2340095A1 Canine growth hormone secretagogue receptor |
| 02/24/2000 | CA2340086A1 A method of transducing mammalian cells, and products related thereto |
| 02/24/2000 | CA2340085A1 Engineered antigen-presenting cells expressing an array of antigens and uses thereof |
| 02/24/2000 | CA2339858A1 Treatment of tumors with oligonucleotides directed to insulin-like growth factor-i receptor |
| 02/24/2000 | CA2339852A1 Agarose format for mammalian cell based reporter assays |
| 02/24/2000 | CA2339748A1 Human stearoyl-coa desaturase-related compositions and methods for treating skin disorders |
| 02/24/2000 | CA2339518A1 Gene |
| 02/24/2000 | CA2339418A1 Human chordin-related proteins and polynucleotides encoding them |
| 02/24/2000 | CA2339414A1 Nucleotide and/or amino-acid sequence controlling the expression of a xylanase promoter-operator nucleotide sequence |
| 02/24/2000 | CA2339409A1 Identification of the gene causing the mouse scurfy phenotype and its human ortholog |
| 02/24/2000 | CA2339406A1 Novel esk potassium channel polypeptide and polynucleotide compositions |
| 02/24/2000 | CA2339405A1 Extracellular adhesive proteins, exadh1 and exadh2 |
| 02/24/2000 | CA2339338A1 Vanadate resistance glycosylation 4 gene |
| 02/24/2000 | CA2339328A1 Peripheral-type benzodiazepine receptor associated proteins, cloning, expression and methods of use |
| 02/24/2000 | CA2339326A1 Differentiation of non-insulin producing cells into insulin producing cells by glp-1 or exendin-4 and uses thereof |
| 02/24/2000 | CA2339304A1 Composition and method of using tumor cells |
| 02/24/2000 | CA2339047A1 Secreted proteins and polynucleotides encoding them |
| 02/24/2000 | CA2338386A1 Proteases and associated proteins |
| 02/24/2000 | CA2335651A1 Gene switch |
| 02/24/2000 | CA2335647A1 Dna constructs comprising protease encoding sequences or inhibitors thereof |
| 02/24/2000 | CA2333914A1 Dna shuffling to produce herbicide selective crops |
| 02/24/2000 | CA2333832A1 Pesticidal toxins and genes from bacillus laterosporus strains |
| 02/24/2000 | CA2332615A1 Dna shuffling of monooxygenase genes for production of industrial chemicals |
| 02/24/2000 | CA2280582A1 Compositions and methods for protecting animals from lentivirus-associated disease such as feline immunodeficiency virus |
| 02/23/2000 | EP0980432A1 Chimeric opg polypeptides |
| 02/23/2000 | EP0980431A1 Antimicrobial peptide |
| 02/23/2000 | EP0980429A2 Human toll-like receptor proteins, related reagents and methods |
| 02/23/2000 | EP0980427A1 Use of ulip proteins in the diagnosis and therapy of cancer and paraneoplastic neurological syndromes |
| 02/23/2000 | EP0980426A1 TYROSINE PHOSPHORYLATED CLEAVAGE FURROW-ASSOCIATED PROTEINS (PSTPIPs) |
| 02/23/2000 | EP0980424A2 Enzymatic nucleic acids: synthesis, selection and use |
| 02/23/2000 | EP0980390A2 Human-cd28 specific monoclonal antibodies for antigen non-specific activation of t-lymphocytes |
| 02/23/2000 | EP0980270A1 Dermal sheath tissue in wound healing |
| 02/23/2000 | EP0980264A2 Mammalian cell transduction for use in gene therapy |
| 02/23/2000 | EP0980250A1 Plant extracts for the treatment of increase bone resorption |
| 02/23/2000 | EP0980205A1 Method of treating malignancies |
| 02/23/2000 | CN1245537A Method for protecting plants |
| 02/23/2000 | CN1245535A Transgenic plants having increased starch content |
| 02/23/2000 | CN1245534A Mammalian cell surface antigens and relating reagents |
| 02/23/2000 | CN1245533A Mammalian chemokines |
| 02/23/2000 | CN1049686C Diagnostics and vaccines for hepatits virus non-A and non-B |
| 02/22/2000 | US6028249 DNA sequences which lead to the formation of levans, plasmids containing these sequences as well as a process for preparing transgenic plants |
| 02/22/2000 | US6028246 Transformed plant cell, comprising in its genome, a dna sequence encoding a crystal protein which is toxic to lepidoptera |
| 02/22/2000 | US6028173 Amino acid sequence of polypeptide involved in axon outgrowth |
| 02/22/2000 | US6028169 Chemokine β-6 antagonists |
| 02/22/2000 | US6027938 Micropathological patient replica based on unadulterated whole blood |
| 02/22/2000 | US6027937 Method for propagation of insecta germ cells |
| 02/22/2000 | US6027935 Gene up-regulated in regenerating liver |
| 02/22/2000 | US6027931 Adeno-associated virus (aav) helper functions that produce low amounts of the long form of aav rep (replication) proteins, resulting in high-efficiency production of recombinant aav |
| 02/22/2000 | US6027924 Isolated nucleic acid molecule coding for tumor rejection antigen precursor MAGE-C1 and uses thereof |
| 02/22/2000 | US6027922 Human foam cells and methods for preparing them, monoclonal antibodies to said foam cells and their pharmaceutical and diagnostic use |
| 02/22/2000 | US6027921 Chimeric proteins for use in transport of a selected substance into cells and DNA encoding chimeric proteins |
| 02/22/2000 | US6027919 BMP-12 and BMP-13 proteins and DNA encoding them |
| 02/22/2000 | US6027917 Bone morphogenetic protein (BMP)-17 and BMP-18 compositions |
| 02/22/2000 | US6027915 Expression augmenting sequence elements (EASE) for eukaryotic expression systems |
| 02/22/2000 | US6027882 Determining genetic predisposition for basal cell carcinoma by detecting a loss-of-function mutation in segment polarity genes; diagnosis of cancer |
| 02/22/2000 | US6027881 Mutant Aequorea victoria fluorescent proteins having increased cellular fluorescence |
| 02/22/2000 | US6027876 Method for monitoring pesticide resistance |
| 02/22/2000 | US6027875 Receptor infection assay |
| 02/22/2000 | US6027727 Inducing transient infertility in a mammal by administering a dose of recombinant zona pellicida proteins from a cat, cattle or cynomolgous monkey and human to stimulate antibody production; vaccines |
| 02/22/2000 | CA2176713C Amphiphilic imidazolinium derivatives |
| 02/22/2000 | CA2091882C Gene therapy for cystic fibrosis |
| 02/22/2000 | CA2071630C Hybrid protein c |
| 02/22/2000 | CA2003455C Immunotherapy involving cd28 stimulation |
| 02/17/2000 | WO2000008469A1 Reporter gene system for use in cell-based assessment of inhibitors of the hepatitis c virus protease |
| 02/17/2000 | WO2000008444A1 Fluorescent assay for biological systems |
| 02/17/2000 | WO2000008443A1 Multiple frequency fluorescence lifetime imaging |
| 02/17/2000 | WO2000008212A1 Gel microdrops in genetic analysis |
| 02/17/2000 | WO2000008209A2 Nucleic acids encoding human tbc-1 protein and polymorphic markers thereof |
| 02/17/2000 | WO2000008199A1 Molecular cloning of a 7tm receptor (gpr31a) |
| 02/17/2000 | WO2000008196A2 Urate oxidase |
| 02/17/2000 | WO2000008194A2 Cell lines for the propagation of mutated herpes viruses |
| 02/17/2000 | WO2000008191A2 Herpes virus vectors for dendritic cells |
| 02/17/2000 | WO2000008187A2 Genes involved in tolerance to environmental stress |
| 02/17/2000 | WO2000008186A1 New salicylic acid inducible genes and promoters from tobacco |
| 02/17/2000 | WO2000008185A1 Nucleic acid molecule coding for beta-amylase, plants synthesizing a modified starch, method of production and applications |
| 02/17/2000 | WO2000008184A1 Plants which synthesize a modified starch, methods for producing the plants, their use, and the modified starch |
| 02/17/2000 | WO2000008181A2 Chp polypeptide, a ligand of pak65 |
| 02/17/2000 | WO2000008180A2 HUMAN cDNAs ENCODING POLYPEPTIDES HAVING KINASE FUNCTIONS |